{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:33:14Z","timestamp":1793363594178,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012359","name":"Promotion and Mutual Aid Corporation for Private Schools of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08783"],"award-info":[{"award-number":["20K08783"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07911"],"award-info":[{"award-number":["23K07911"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016925","name":"The Takeda Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.imlet.2025.107066","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:04:45Z","timestamp":1754492685000},"page":"107066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A shared monocyte cytokine signature induced by serum from patients with systemic lupus erythematosus and anti-MDA5 antibody-positive dermatomyositis through the type I interferon pathway"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9740-3836","authenticated-orcid":false,"given":"Shohei","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8088-1746","authenticated-orcid":false,"given":"Yuko","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4541-2636","authenticated-orcid":false,"given":"Hideto","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1654-0119","authenticated-orcid":false,"given":"Yasuhiro","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-2603","authenticated-orcid":false,"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2025.107066_bib0001","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2025.107066_bib0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rdc.2011.01.002","article-title":"Polymyositis and dermatomyositis: pathophysiology","volume":"37","author":"Nagaraju","year":"2011","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.imlet.2025.107066_bib0003","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107066_bib0004","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","article-title":"Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease","volume":"73","author":"Sordet","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.imlet.2025.107066_bib0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11926-996-0025-3","article-title":"Myositis specific autoantibodies","volume":"8","author":"Targoff","year":"2006","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.imlet.2025.107066_bib0006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11926-024-01164-7","article-title":"Recent updates on the pathogenesis of inflammatory myopathies","volume":"26","author":"Musai","year":"2024","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.imlet.2025.107066_bib0007","doi-asserted-by":"crossref","first-page":"kew431","DOI":"10.1093\/rheumatology\/kew431","article-title":"Type I interferon\u2013mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy","volume":"56","author":"Psarras","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2025.107066_bib0008","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.imlet.2025.107066_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","article-title":"Type I interferons in the pathogenesis and treatment of autoimmune diseases","volume":"59","author":"Jiang","year":"2020","journal-title":"Clin. Rev. Allerg. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606456","article-title":"Type I Interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways","volume":"11","author":"Mazewski","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0012","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS\u2013STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.imlet.2025.107066_bib0013","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jaci.2015.04.008","article-title":"Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus","volume":"136","author":"O'Gorman","year":"2015","journal-title":"J. Allergy Clin. Immun."},{"key":"10.1016\/j.imlet.2025.107066_bib0014","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2017.03.010","article-title":"Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients","volume":"81","author":"O'Gorman","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2025.107066_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102581","article-title":"Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes","volume":"117","author":"Okamato","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2025.107066_bib0016","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2025.107066_bib0017","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2025.107066_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2025.107066_bib0019","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/annrheumdis-2020-219012","article-title":"JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib","volume":"80","author":"Traves","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2025.107066_bib0020","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.celrep.2018.09.001","article-title":"IFN\u03b1 impairs autophagic degradation of mtDNA promoting autoreactivity of SLE monocytes in a STING-dependent fashion","volume":"25","author":"Gkirtzimanaki","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2025.107066_bib0021","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107066_bib0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody\u2013DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2025.107066_bib0023","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","article-title":"A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs","volume":"184","author":"Denny","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0024","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3326","article-title":"Self-reactive IgE exacerbates interferon responses associated with autoimmunity","volume":"17","author":"Henault","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107066_bib0026","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","article-title":"Apoptosis-derived membrane vesicles drive the cGAS\u2013STING pathway and enhance type I IFN production in systemic lupus erythematosus","volume":"77","author":"Kato","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2025.107066_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000607","article-title":"Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus","volume":"9","author":"Ruacho","year":"2022","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.imlet.2025.107066_bib0028","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00296-017-3888-x","article-title":"Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study","volume":"38","author":"Zivkovic","year":"2018","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.imlet.2025.107066_bib0029","doi-asserted-by":"crossref","first-page":"e0343","DOI":"10.1097\/MD.0000000000010343","article-title":"Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: a case-control study","volume":"97","author":"Dong","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.imlet.2025.107066_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263778","article-title":"Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios","volume":"17","author":"Ngamjanyaporn","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2025.107066_bib0031","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.humimm.2010.06.004","article-title":"Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease","volume":"71","author":"Brugos","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0032","doi-asserted-by":"crossref","first-page":"eabf1970","DOI":"10.1126\/science.abf1970","article-title":"Single-cell RNA-seq reveals cell type\u2013specific molecular and genetic associations to lupus","volume":"376","author":"Perez","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.imlet.2025.107066_bib0033","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","article-title":"Mapping systemic lupus erythematosus heterogeneity at the single-cell level","volume":"21","author":"Nehar-Belaid","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0034","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of lupus nephritis patients","volume":"20","author":"Berthier","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.41566","article-title":"Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis\u2013associated interstitial lung disease","volume":"73","author":"Gono","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2025.107066_bib0036","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/kez185","article-title":"Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD","volume":"58","author":"Horiike","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2025.107066_bib0037","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/cei.13404","article-title":"A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis","volume":"199","author":"Peng","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2025.107066_bib0038","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/rheumatology\/keab371","article-title":"Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease","volume":"61","author":"Gono","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2025.107066_bib0039","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMc1900045","article-title":"Tofacitinib in amyopathic dermatomyositis\u2013associated interstitial lung disease","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107066_bib0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00296-024-05551-2","article-title":"Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease","volume":"44","author":"Harada","year":"2024","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.imlet.2025.107066_bib0041","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241294000","article-title":"The efficacy and safety of tofacitinib in anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis associated interstitial lung disease: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2024","journal-title":"Ther. Adv. Respir. Dis."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:35:06Z","timestamp":1772793306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"alternative-id":["S0165247825000999"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107066","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A shared monocyte cytokine signature induced by serum from patients with systemic lupus erythematosus and anti-MDA5 antibody-positive dermatomyositis through the type I interferon pathway","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107066"}}